Teos Therapeutics has potential lung cancer treatment despite issues and strong financial position. Read here to know why we ...

Biogen (BIIB) closed near a 52-week low of $150.03. The stock trades at a discount because the biotech firm lacks growth ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.01% of ...

Investing.com 英国 100 中表现最好的股票为GSK plc (LON: GSK )，上涨1.06%（14.00点），收盘报价为1,333.50。同时，HALEON PLC (LON: HLN ...

GSK PLC GSK shares rose 1.06% to £13.34 Tuesday, on what proved to be an all-around dismal trading session for the stock ...

London’s FTSE 100 was down 0.5% at 8,218.94 in afternoon trade on Tuesday. Bunzl was under the cosh as it said volume growth ...

In economic news, UK unemployment remained steady in the three months to October, while wage growth accelerated, according to the Office for National Statistics. The unemployment rate held firm at 4.3 ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

AbbVie has a lofty goal for 2025 — and it could stoke the beleaguered AbbVie stock. The immunology powerhouse known for ...

GSK (GSK) announced the Committee for Medicinal Products for Human Use, CHMP, of the European Medicines Agency, EMA, has recommended expanding the approval of Jemperli in combination with chemotherapy ...

GSK (GSK) announced that the US Food and Drug Administration, FDA, has granted Breakthrough Therapy Designation, BTD, for ...

Myriad Genetics, Inc. MYGN is driving innovation across Oncology, Women's Health and Pharmacogenomics, and heavily invests in labs and digital capabilities. Thecompany’s Oncology growth strategy ...